ESMO 2022 Conference Coverage
Playback speed
10 seconds
ESMO 2022 Updates on the Randomized Phase III VANCE Study: Gem & Carbo Followed by Epstein-Barr Virus-Specific Autologous Cytotoxic T-Lymphocytes vs. the Same Chemo as 1L Treatment for Advanced Nasopharyngeal Carcinoma
By
ESMO 2022 Conference Coverage
FEATURING
Han Chong Toh
By
ESMO 2022 Conference Coverage
FEATURING
Han Chong Toh
0 views
September 22, 2022
Comments 0
Login to view comments.
Click here to Login
Head and Neck